AKEBIA THERAPEUTICS
Akebia Therapeutics, Inc., a pharmaceutical company, focuses on treatments for ischemia and improvement of vascular disease. It engages in the clinical development of compounds for the treatment of anemia and ischemia-related disorders. The company offers Omacor for hypertriglyceridemia; and Actonel for osteoporosis. Its products include prolyl hydroxylase enzyme and phosphatase enzyme. Akebia Therapeutics, Inc. was founded in 2007 and is based in Cincinnati, Ohio.
AKEBIA THERAPEUTICS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2007-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.akebia.com
Total Employee:
101+
Status:
Active
Contact:
(617) 871-2098
Total Funding:
442.5 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Google Analytics Google Maps
Similar Organizations
Aardvark Therapeutics
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders.
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Carmot Therapeutics
Carmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.
Celcuity
Celcuity is a biotechnology company translating discoveries of new cancer sub-types into expanded therapeutic options for cancer patients.
HepaRegeniX
HepaRegeniX is developing drugs for treating acute and chronic liver diseases.
Kala Pharmaceuticals
Kala Pharmaceuticals develops novel treatments for diseases that affect mucosal tissues.
Nektar Therapeutics
Nektar Therapeutics develops therapeutics based on its advanced polymer conjugate chemistry technology platform.
Nurix Therapeutics
Nurix Therapeutics is a biopharmaceutical company that focuses on the development and discovery of small molecule drugs.
Annovis Bio
Annovis Bio develops novel treatments for Alzheimer’s disease, Parkinson’s disease, and other neurodegenerative disorders.
Sarepta Therapeutics
Sarepta Therapeutics focuses on the discovery and development of precision genetic medicine to treat rare diseases.
Current Advisors List
Board_member
Board_member
Board_member
Board_member
2021-02-01
Board_member
Board_member
Board_member
2018-01-01
Current Employees Featured
John Butler President & CEO @ Akebia Therapeutics
President & CEO
2013-09-01
Erik Ostrowski Senior Vice President, Chief Financial Officer & Chief Business Officer @ Akebia Therapeutics
Senior Vice President, Chief Financial Officer & Chief Business Officer
2024-06-01
Nicholas Grund Chief Commercial Officer @ Akebia Therapeutics
Chief Commercial Officer
2024-01-01
Steven Burke Chief Medical Officer @ Akebia Therapeutics
Chief Medical Officer
2019-08-01
Ellen Snow Chief Financial Officer @ Akebia Therapeutics
Chief Financial Officer
2023-01-01
Peter Manni Director Strategic Sourcing @ Akebia Therapeutics
Director Strategic Sourcing
2019-12-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-06-28 | Keryx Biopharmaceuticals | Keryx Biopharmaceuticals acquired by Akebia Therapeutics | N/A |
Investors List
BlackRock
BlackRock investment in Post-IPO Debt - Akebia Therapeutics
Pharmakon Advisors
Pharmakon Advisors investment in Post-IPO Debt - Akebia Therapeutics
Orchard Venture Partners
Orchard Venture Partners investment in Series C - Akebia Therapeutics
Kearny Venture Partners
Kearny Venture Partners investment in Series C - Akebia Therapeutics
Athenian Venture Partners
Athenian Venture Partners investment in Series C - Akebia Therapeutics
Novartis Venture Fund
Novartis Venture Fund investment in Series C - Akebia Therapeutics
Satter Investment Management
Satter Investment Management investment in Series C - Akebia Therapeutics
Triathlon Medical Venture Partners
Triathlon Medical Venture Partners investment in Series C - Akebia Therapeutics
Novo Holdings
Novo Holdings investment in Series C - Akebia Therapeutics
AgeChem Venture Fund
AgeChem Venture Fund investment in Series C - Akebia Therapeutics
Key Employee Changes
Official Site Inspections
http://www.akebia.com Semrush global rank: 3.19 M Semrush visits lastest month: 4.66 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Akebia Therapeutics"
Home - PDUFA - Akebia Therapeutics
You are leaving akebia.com, a website of Akebia Therapeutics, Inc. Akebia does not review or control the content of non-Akebia websites, and this hyperlink does not constitute an endorsement by Akebia of the site’s content. Akebia’s …See details»
Akebia Therapeutics - Crunchbase Company Profile & Funding
Organization. Akebia Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. ... Akebia Therapeutics, Inc., a …See details»
Akebia Therapeutics Announces Appointment of Nicholas Grund …
CAMBRIDGE, Mass., Jan. 9, 2024 /PRNewswire/ -- Akebia Therapeutics ®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by …See details»
Investor Relations | Akebia Therapeutics
Akebia Therapeutics Since our founding in 2007, Akebia (Nasdaq: AKBA) has been focused on achieving better outcomes for people with kidney disease. We are a leader in the renal community – a fully integrated biopharmaceutical …See details»
Akebia Therapeutics Announces New Chief Financial Officer
Jun 18, 2020 "Akebia's unwavering commitment to innovation and advancing patient care is inspiring, and I'm thrilled to become part of it. I look forward to building upon Akebia's financial …See details»
Patients & Families - Akebia Therapeutics
At Akebia, we work to help better the lives of people impacted by kidney disease. We count ourselves among the broad renal community that is invested in kidney health and we work collaboratively with multiple advocacy organizations. Visit …See details»
Home | Akebia Medical Affairs
Call Akebia Medical Information. 1-844-445-3799. To report an adverse event or product complaint, select option 2. MED-NA-US-0044 (v9.0) 09/24. Resources Disease Education …See details»
Akebia Therapeutics Company Profile - Office Locations ... - Craft
Oct 8, 2024 Akebia Therapeutics has 4 employees at their 1 location and $194.62 m in annual revenue in FY 2023. See insights on Akebia Therapeutics including office locations, …See details»
Akebia Therapeutics Announces Multiple Positive Business Updates
2 days ago Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced multiple …See details»
Akebia Therapeutics Announces Multiple Positive Business Updates
2 days ago “We believe Akebia is entering a transformational year with the U.S. market availability of Vafseo, which we believe could become a new standard of care for patients with …See details»
Akebia signs commercial supply contract with dialysis organization
Oct 22, 2024 Akebia expects Vafseo will be available in the U.S. in January 2025. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>See details»
Akebia Therapeutics Signs Commercial Supply Contract with …
Oct 22, 2024 About Akebia Therapeutics Akebia Therapeutics , Inc. is a fully integrated biopharmaceutical company with the purpose to better the lives of people impacted by kidney …See details»
Akebia Therapeutics Signs Commercial Supply Contract with …
Oct 22, 2024 Akebia Therapeutics®, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that it …See details»
AkebiaCares for Healthcare Providers
AkebiaCares supports your patients with information and resources that can help people start and stay on their Akebia medication. Get access to helpful resources to support your patients and …See details»
Akebia announces ‘multiple positive business updates’
2 days ago In addition, Akebia recently signed a Vafseo commercial supply agreement with a leading dialysis organization. Akebia now has contracts in place with dialysis organizations …See details»
Akebia Therapeutics Announces Multiple Positive Business Updates
2 days ago In addition, Akebia recently signed a Vafseo commercial supply agreement with a leading dialysis organization. Akebia now has contracts in place with dialysis organizations …See details»
Akebia Therapeutics Announces Multiple Positive Business Updates
2 days ago Akebia has secured broad access for Vafseo as the company has now entered into commercial supply agreements with dialysis organizations treating nearly 100% of patients on …See details»
Global Medical Education Grant Request Application - Akebia …
Organization (if applicable) It is Akebia’s policy not to pay for or support meals, travel, or other expenses for any attendees of any program funded by an educational grant from Akebia. For …See details»
Akebia - Products, Competitors, Financials, Employees, …
Akebia is a company that specializes in digital transformation for businesses and public administrations within the technology and digital services industry. Their offerings include …See details»
Akebia's Vafseo Launch Secures Coverage for Nearly All U.S.
2 days ago Akebia has secured broad access for Vafseo as the company has now entered into commercial supply agreements with dialysis organizations treating nearly 100% of patients on …See details»